LSD for mental health research makes a come back.

After the demise of the Harvard Psychobicilin project 40 years ago
research into hallucinogeons was trapped by the stigmas associated with
hedonic use of the drug. There's been a recent resurgence and there are
some preliminary studies showing promising results for the treatment of
mental illnesses.

From this blog article
http://historypsychiatry.wordpress.com/2010/04/12/ect-and-lsd/

I found a link to another article recently published in the New York Times.
http://www.nytimes.com/2010/04/12/science/12psychedelics.html

Which refers to the study
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse. 2008.
"*Mystical-type experiences occasioned by psilocybin mediate the
attribution of personal meaning and spiritual significance 14 months
later.*" /Journal of Psychopharmacology,/ 22(6), 621-632.

And that's available for anyone to read at
http://csp.org/psilocybin/

And may have been funded by
http://www.heffter.org/
"
The Heffter Research Institute promotes research of the highest
scientific quality with the classical hallucinogens and related
compounds (sometimes called psychedelics) in order to contribute to a
greater understanding of the mind, leading to the improvement of the
human condition, and the alleviation of suffering.
"

Simplified coverage of the impact of this research for the promotion of
entheogens is available on this useful blog page.
http://jonesthought.wordpress.com/category/entheogens/page/2/